Chimeric haemopoietic growth factors

Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

Hochaus S, Wassmann B, Egerer G (1998) Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells. Bone Marrow Transplantation 22:625-30.

Holyoake T, Alcorn M (1994) CD34 positive haemopoietic cells: biology and clinical applications. Blood Reviews 8:113-24.

Hubel K, Dale D, Liles W (2002) Therapeutic use of cytokines to modulate phagocytic function in the treatment of infectious diseases: current status of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor and interferon-gamma. Journal of Infectious Diseases 185:1490-501.

Ihle J, Kerr IM (1995) Jaks and Stats in signalling by the cytokine receptor superfamily. Trends in Genetics 11: 69 -74.

Kauchansky K (1995) Thrombopoietin: the primary regulator of platelet production. Blood 86:419-31.

Lee S, Radford J, Dobson L (1998) Recombinant human granulocyte colony stimulating factor (filgrastim) following high dose chemotherapy and peripheral blood progenitor cell rescue in high grade non-Hodgkin's lymphoma: clinical benefits at no extra cost. British Journal of Cancer 77:1294-9.

Ludwig H, Rai K, Blade J et al. (2002) Management of disease-related anaemia in patients with multiple myeloma or chronic lymphatic leukaemia: epoetin treatment recommendations. The Haematology Journal 3:121-30.

Mangi M, Newland AC (1999) Interleukin-3 in haematology and oncology; current state of knowledge and future directions. Cytokines and Cellular Molecular Therapy 5: 87-95.

Maxwell PH, Pugh CW, Ratcliffe PJ (2001) The pVHL-hIF1 system. A key mediator of oxygen homeostasis. Advances in Experimental Medical Biology 502: 365-76.

Nemuniatis J, Buckner CD, Singer JW etal. (1990) Use of recombinant GM-CSF in graft failure. Blood 76:245-53.

Nemunaitis J, Anasetti C, Storb R (1992) Phase II trial of recombinant human GM-CSF in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 79:2572-7.

Osterborg A, Brandberg Y, Molostova V etal. (2002) Randomised double blind placebo controlled trial of recombinant human erythropoietin in haematological malignancies. Journal of Clinical Oncology 20:2486-94.

Ozer H, Armitage J, Bennett C et al. (2000) Update of recommendations for the use of haematopoietic colony stimulating factors: evidence-based clinical practice guidelines. Journal of Clinical Oncology 18: 3558-70.

Pagliuca A, Carrington PA, Pettengell R etal. (2003) Guidelines on the use of colony-stimulating factors in haematological malignancies. British Journal of Haematology 123:22-33.

Price T (2002) Granulocyte transfusion in the G-CSF era. International Journal of Haematology 76: 77-80.

Rizzo JD, Lichtin A, Woolf S et al. (2002) Use of epoetin in patients with cancer: evidence based clinical practice guidelines of the American Society of Haematology. Blood 100:2303-20.

Russell NH, Gratwohl A, Schmitz N (1996) The place of blood stem cells in allogeneic transplantation. British Journal of Haematology 93: 747-53.

Schmitz N, Linch DC, Dreger P etal. (1996) A randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet347: 3563-3567.

Sheridan WP, Begley CG, Juttner CA etal. (1992) Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339: 640-4.

Storek J, Gooley T, Siadek M etal. (1997) Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft versus host disease. Blood 90:4705-9.

Stroncek D, Clay M, Petzoldt M etal. (1996) Treatment of normal individuals with granulocyte colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion 36: 601-10.

Introduction, 318

Lysosomes, 318

Pathophysiology of lysosomal storage disorders, 318

Prevalence, 319 Diagnosis, 319 Therapy, 320 Prognosis, 324

Clinical manifestations, 324

Gaucher's disease, 324 Fabry's disease, 329 Selected bibliography, 329

Introduction, 318

Lysosomes, 318

Pathophysiology of lysosomal storage disorders, 318

Prevalence, 319 Diagnosis, 319 Therapy, 320 Prognosis, 324

Clinical manifestations, 324

Gaucher's disease, 324 Fabry's disease, 329 Selected bibliography, 329

Was this article helpful?

0 0
How To Bolster Your Immune System

How To Bolster Your Immune System

All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.

Get My Free Audio Book


Post a comment